Barwood buys brace of South Cambridge labs
Barwood Capital’s Regional Property Growth Fund V has bought laboratory and industrial space in Whittlesford, South Cambridge, for £12.8m.
The 11,000 sq ft scheme, known as Recodery, was redeveloped by Gen Two Real Estate last year and let to Alchemab Therapeutics and Constructive Bio. The transaction also includes two adjoining industrial warehouses, totalling 27,500 sq ft.
Following the acquisition, Barwood plans to reconfigure the industrial facilities into fitted laboratory space and create a life sciences hub in the South Cambridge Science Cluster. The site is 6.2 miles south of the city centre near other established science parks including the Cambridge Biomedical Campus, Babraham Research Park, Wellcome Genome Campus and Unity Campus.
Barwood Capital’s Regional Property Growth Fund V has bought laboratory and industrial space in Whittlesford, South Cambridge, for £12.8m.
The 11,000 sq ft scheme, known as Recodery, was redeveloped by Gen Two Real Estate last year and let to Alchemab Therapeutics and Constructive Bio. The transaction also includes two adjoining industrial warehouses, totalling 27,500 sq ft.
Following the acquisition, Barwood plans to reconfigure the industrial facilities into fitted laboratory space and create a life sciences hub in the South Cambridge Science Cluster. The site is 6.2 miles south of the city centre near other established science parks including the Cambridge Biomedical Campus, Babraham Research Park, Wellcome Genome Campus and Unity Campus.
Gen Two will continue its involvement in the project going forward as the development partner and investor.
Jonathon Ellerington, investment director at Barwood, said: “The acquisition provides an opportunity to reconfigure underutilised properties in a key, strategic location, and in a sector which is underpinned by strong underlying tailwinds.
“The refurbishment and reconfiguring of these units will also serve to improve the area and provide employment opportunities. It will also support life sciences businesses to grow through providing laboratory space at a time when the market is starved of supply.”
Daniel Sterling, co-founder of Gen Two Real Estate, said: “Since developing Recodery back in 2023 for Constructive Bio, it has been very satisfying to see the team grow into the space as well as completing a series A funding of $58m in September 2024.”
Earlier this month, Gen Two launched the sale of the 125,619 sq ft Alchemy scheme in Fowlmere.
Photo from Gen Two
